{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:23:07Z","timestamp":1764174187999},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s13277-015-3964-3","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T05:43:15Z","timestamp":1443678195000},"page":"3123-3134","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas"],"prefix":"10.1007","volume":"37","author":[{"given":"Nehad M. R. Abd","family":"El-Maqsoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab Rifat","family":"Tawfiek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Abdelmeged","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Fathy Abdel","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa A. E.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"issue":"1","key":"3964_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2009.06.014","volume":"41","author":"JA Bishop","year":"2010","unstructured":"Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol. 2010;41(1):20\u20135.","journal-title":"Hum Pathol"},{"issue":"9","key":"3964_CR2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.5858\/arpa.2012-0635-OA","volume":"137","author":"AF Brown","year":"2013","unstructured":"Brown AF, Sirohi D, Fukuoka J, Cagle PT, Policarpio-Nicolas M, Tacha D, et al. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung. Arch Pathol Lab Med. 2013;137(9):1274\u201381.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"3964_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PAS.0b013e3182036d05","volume":"35","author":"S Mukhopadhyay","year":"2011","unstructured":"Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5\/6. Am J Surg Pathol. 2011;35(1):15\u201325.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3964_CR4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.lungcan.2005.11.012","volume":"52","author":"A Stang","year":"2006","unstructured":"Stang A, Pohlabeln H, Muller KM, Jahn I, Giersiepen K, Jockel KH. Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case\u2013control study. Lung Cancer. 2006;52(1):29\u201336.","journal-title":"Lung Cancer"},{"issue":"4","key":"3964_CR5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/dc.21563","volume":"40","author":"T Antic","year":"2012","unstructured":"Antic T, Gong Y, Sneige N. Tumor type and single cell\/mesothelial-like cell pattern of breast carcinoma metastases in pleural and peritoneal effusions. Diagn Cytopathol. 2012;40(4):311\u20135.","journal-title":"Diagn Cytopathol"},{"issue":"9","key":"3964_CR6","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.20202","volume":"100","author":"GR Varadhachary","year":"2004","unstructured":"Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer. 2004;100(9):1776\u201385.","journal-title":"Cancer"},{"issue":"1","key":"3964_CR7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/10520295.2011.591838","volume":"87","author":"J Ye","year":"2012","unstructured":"Ye J, Hameed O, Findeis-Hosey JJ, Fan L, Li F, McMahon LA, et al. Diagnostic utility of PAX8, TTF-1 and Napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung. Biotech Histochem. 2012;87(1):30\u20134.","journal-title":"Biotech Histochem"},{"issue":"4","key":"3964_CR8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/JTO.0b013e3181d40fac","volume":"5","author":"PS Loo","year":"2010","unstructured":"Loo PS, Thomas SC, Nicolson MC, Fyfe MN, Kerr KM. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol. 2010;5(4):442\u20137.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"3964_CR9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/cncy.20108","volume":"118","author":"LM Stoll","year":"2010","unstructured":"Stoll LM, Johnson MW, Gabrielson E, Askin F, Clark DP, Li QK. The utility of Napsin-A in the identification of primary and metastaticlung adenocarcinoma among cytologically poorly differentiated carcinomas. Cancer Cytopathol. 2010;118(6):441\u20139.","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"3964_CR10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1158\/1078-0432.CCR-09-2638","volume":"16","author":"JA Bishop","year":"2013","unstructured":"Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res. 2013;16(2):610\u20139.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3964_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-5002(03)00194-6","volume":"41","author":"T Hirano","year":"2003","unstructured":"Hirano T, Gong Y, Yoshida K, Kato Y, Yashima K, Maeda M, et al. Usefulness of TAO2 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma. Lung Cancer. 2003;41(2):155\u201362.","journal-title":"Lung Cancer"},{"issue":"4","key":"3964_CR12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAI.0b013e318205b059","volume":"19","author":"J Ye","year":"2011","unstructured":"Ye J, Findeis-Hosey JJ, Yang Q, McMahon LA, Yao JL, Li F, et al. Combination of napsin A and TTF-1immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl Immunohistochem Mol Morphol. 2011;19(4):313\u20137.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"3964_CR13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1309\/CADCVWHR2QF6JMVN","volume":"128","author":"K Gu","year":"2007","unstructured":"Gu K, Shah V, Ma C, Zhang L, Yang M. Cytoplasmic immunoreactivity of thyroid transcription factor-1 (clone 8G7G3\/1) in hepatocytes true positivity or cross-reaction? Am J Clin Pathol. 2007;128(3):382\u20138.","journal-title":"Am J Clin Pathol"},{"issue":"37","key":"3964_CR14","doi-asserted-by":"crossref","first-page":"35574","DOI":"10.1074\/jbc.M304885200","volume":"278","author":"M DeFelice","year":"2003","unstructured":"DeFelice M, Silberschmidt D, DiLauro R, Xu Y, Wert SE, Weaver TE, et al. TTF-1 phosphorylation is required for peripheral lung morphogenesis, perinatal survival, and tissue-specific gene expression. J Biol Chem. 2003;278(37):35574\u201383.","journal-title":"J Biol Chem"},{"issue":"2","key":"3964_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5858\/arpa.2011-0320-OA","volume":"136","author":"BM Turner","year":"2012","unstructured":"Turner BM, Cagle PT, Sainz IM, Fukuoka J, Shen SS, Jagirdar J. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Arch Pathol Lab Med. 2012;136(2):163\u201371.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"3964_CR16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.anndiagpath.2012.07.006","volume":"17","author":"MJ Kim","year":"2013","unstructured":"Kim MJ, Shin HC, Shin KC, Ro JY. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens. Ann Diagn Pathol. 2013;17(1):85\u201390.","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"3964_CR17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.humpath.2014.01.005","volume":"45","author":"MH Ao","year":"2014","unstructured":"Ao MH, Zhang H, Sakowski L, Sharma R, Illei PB, Gabrielson E, et al. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer. Hum Pathol. 2014;45(5):926\u201334.","journal-title":"Hum Pathol"},{"key":"3964_CR18","first-page":"923","volume":"30","author":"T Sun","year":"2014","unstructured":"Sun T, Xie H, Kong L. Role of p40 (\u0394NP63), p63, thyroid transcritpion factor-1 and Napsin A in differential diagnosis between lung squamous cell carcinoma and lung adenocarcinoma. Acta Med Mediterr. 2014;30:923\u20137.","journal-title":"Acta Med Mediterr"},{"key":"3964_CR19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2164-11-306","volume":"11","author":"R Nitsch","year":"2010","unstructured":"Nitsch R, Di Dato V, di Gennaro A, de Cristofaro T, Abbondante S, De Felice M, et al. Comparative genomics reveals a functional thyroidspecific element in the far upstream region of the PAX8 gene. BMC Genomics. 2010;11:306.","journal-title":"BMC Genomics"},{"issue":"7","key":"3964_CR20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/PAS.0b013e3181dc5e8a","volume":"34","author":"R Albadine","year":"2010","unstructured":"Albadine R, Schultz L, Illei P, Ertoy D, Hicks J, Sharma R, et al. PAX8 (+)\/p63 (\u2212) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol. 2010;34(7):965\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"3964_CR21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/PAS.0b013e3181962dcd","volume":"33","author":"TL Lotan","year":"2009","unstructured":"Lotan TL, Ye H, Melamed J, Wu XR, Shih Ie M, Epstein JI. Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma. Am J Surg Pathol. 2009;33(7):1037\u201341.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3964_CR22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","volume":"24","author":"A Ozcan","year":"2011","unstructured":"Ozcan A, Shen SS, Hamilton C, Anjana K, Coffey D, Krishnan B, et al. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol. 2011;24(6):751\u201364.","journal-title":"Mod Pathol"},{"issue":"6","key":"3964_CR23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","volume":"35","author":"AR Laury","year":"2011","unstructured":"Laury AR, Perets R, Piao H, Krane JF, Barletta JA, French C, et al. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol. 2011;35(6):816\u201326.","journal-title":"Am J Surg Pathol"},{"key":"3964_CR24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/2277-9175.129366","volume":"3","author":"M Heidarpour","year":"2014","unstructured":"Heidarpour M, Tavanafar Z. Diagnostic utility of PAX8 in differentiation of mullerian from non-mullerian tumors. Adv Biomed Res. 2014;3:96.","journal-title":"Adv Biomed Res"},{"issue":"5","key":"3964_CR25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3892\/ol_00000162","volume":"1","author":"P Zhang","year":"2010","unstructured":"Zhang P, Han YP, Huang L, Li Q, Ma DL. Value of Napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma. Oncol Lett. 2010;1(5):899\u2013903.","journal-title":"Oncol Lett"},{"issue":"11","key":"3964_CR26","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/PAS.0b013e3181131e21","volume":"31","author":"K Siami","year":"2007","unstructured":"Siami K, McCluggage WG, Ordonez NG, Euscher ED, Malpica A, Sneige N, et al. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am J Surg Pathol. 2007;31(11):1759\u201363.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3964_CR27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","volume":"104","author":"NJ Bowen","year":"2007","unstructured":"Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB, et al. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 2007;104(2):331\u20137.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3964_CR28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/modpathol.3801002","volume":"21","author":"D Nonaka","year":"2008","unstructured":"Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol. 2008;21(2):192\u2013200.","journal-title":"Mod Pathol"},{"issue":"5","key":"3964_CR29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","volume":"34","author":"AR Laury","year":"2010","unstructured":"Laury AR, Hornick JL, Perets R, Krane JF, Corson J, Drapkin R, et al. PAX 8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 2010;34(5):627\u201335.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"3964_CR30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/dc.21442","volume":"39","author":"W Wiseman","year":"2011","unstructured":"Wiseman W, Michael CW, Roh MH. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic M\u00fcllerian carcinoma in effusions. Diagn Cytopathol. 2011;39(9):651\u20136.","journal-title":"Diagn Cytopathol"},{"issue":"12","key":"3964_CR31","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/PAS.0b013e3181f7dae3","volume":"34","author":"J Terry","year":"2010","unstructured":"Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol. 2010;34(12):1805\u201311.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3964_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.6058\/jlc.2012.11.1.21","volume":"11","author":"GY Kim","year":"2012","unstructured":"Kim GY, Lim SJ, Kim WS, Lee GK. A minimal immunohistochemical panel for subtyping poorly differentiated non-small cell lung carcinoma: a tissue microarray study simulating small biopsy conditions. J Lung Cancer. 2012;11(1):21\u201332.","journal-title":"J Lung Cancer"},{"issue":"6","key":"3964_CR33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0463.2008.00932.x","volume":"116","author":"P Downey","year":"2008","unstructured":"Downey P, Cummins R, Moran M, Gulmann C. If it\u2019s not CK5\/6 positive, TTF-1 negative it\u2019s not a squamous cell carcinoma of lung. APMIS. 2008;116(6):526\u20139.","journal-title":"APMIS"},{"issue":"4","key":"3964_CR34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0b013e3182025f66","volume":"19","author":"D Tacha","year":"2011","unstructured":"Tacha D, Zhou D, Cheng L. Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study. Appl Immunohistochem Mol Morphol. 2011;19(4):293\u20139.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"12","key":"3964_CR35","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.5858\/arpa.2012-0072-OA","volume":"136","author":"A Ozcan","year":"2012","unstructured":"Ozcan A, de la Roza G, Ro JY, Shen SS, Truong LD. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. Arch Pathol Lab Med. 2012;136(12):1541\u201351.","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"3964_CR36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/dc.21590","volume":"40","author":"SM Knoepp","year":"2012","unstructured":"Knoepp SM, Kunju LP, Roh MH. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology. Diagn Cytopathol. 2012;40(8):667\u201372.","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"3964_CR37","first-page":"17","volume":"54","author":"L Liliac","year":"2013","unstructured":"Liliac L, Carcangiu ML, Canevari S, C\u0103runtu ID, Ciobanu Apostol DG, Danciu M, et al. The value of PAX8 and WT1 molecules in ovarian cancer diagnosis. Rom J Morphol Embryol. 2013;54(1):17\u201327.","journal-title":"Rom J Morphol Embryol"},{"issue":"4","key":"3964_CR38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/PAI.0000000000000065","volume":"23","author":"M Wang","year":"2015","unstructured":"Wang M, Ma H, Pan Y, Xiao W, Li J, Yu J, et al. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors. Appl Immunohistochem Mol Morphol. 2015;23(4):280\u20137.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"8","key":"3964_CR39","first-page":"567","volume":"39","author":"GX Tong","year":"2011","unstructured":"Tong GX, Devaraj K, Hamele-Bena D, Yu WM, Turk A, Chen X, et al. Pax8: a marker for carcinoma of M\u00fcllerian origin in serous effusions. Diagn Cytopathol. 2011;39(8):567\u201374.","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"3964_CR40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3892\/ol.2013.1121","volume":"5","author":"L Xiang","year":"2013","unstructured":"Xiang L, Kong B. PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas. Oncol Lett. 2013;5(3):735\u20138.","journal-title":"Oncol Lett"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3964-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3964-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3964-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3964-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T02:14:10Z","timestamp":1599617650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3964-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3964"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3964-3","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]}}}